Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Avalon GloboCare ( (ALBT) ) has shared an announcement.
Avalon GloboCare Corp. announced its partnership with Pounds Transformation Clinics to launch the ‘BrAce 4 Impact Challenge Series,’ incorporating the KetoAir™ breathalyzer as a motivational tool in weight management programs. Following a successful pilot ending on March 18, 2025, the challenge series aims to enhance patient engagement and accountability, with the KetoAir™ providing real-time feedback on ketone levels, thus supporting long-term lifestyle changes and improved health outcomes.
More about Avalon GloboCare
Avalon GloboCare Corp. is a commercial-stage company focused on developing and delivering precision diagnostic consumer products. The company markets the KetoAir™ breathalyzer device and plans to expand its diagnostic applications. Avalon also owns and operates commercial real estate.
YTD Price Performance: 39.94%
Average Trading Volume: 76,152
Technical Sentiment Signal: Buy
Current Market Cap: $5.25M
Learn more about ALBT stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue